Blood test could spot lung transplant trouble early

NCT ID NCT06679257

Recruiting now Diagnosis Sponsor: Jesper Magnusson Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a new blood test to quickly identify damage or infection in lung transplant patients. Researchers will take blood samples at regular times and when problems occur, then compare the results to standard tests. The goal is to make diagnosis faster and easier, which could help patients live longer after a lung transplant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cell-free DNA blood test
What this could lead to: If successful, this blood test could help doctors quickly identify lung transplant damage or infection, potentially improving survival and reducing the need for invasive biopsies.
What could go wrong: This is an early observational study with 146 participants. The test may not be accurate enough to replace current methods, and results may not apply to all transplant patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG TRANSPLANT FAILURE AND REJECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Rejection, Psychology transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG TRANSPLANT FAILURE AND REJECTION LUNG TRANSPLANT INFECTION

Contacts and locations

Locations

Sahlgrenska University hospital
RECRUITING

Gothenburg, Västra Götaland County, 413 45, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.